Vaccinex Inc (VCNX): analysts target pps$105.00 wait what?pip...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	81
Posts	6373
Boards Moderated	4
Alias Born	01/14/2015

81vette

Re: None

Friday, 10/06/2023 11:09:38 AM

Friday, October 06, 2023 11:09:38 AM

analysts target pps$105.00 wait what?pipeline is that good?thats hard to believe

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent VCNX News

Vaccinex Reports 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/02/2024 12:30:00 PM
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 03/27/2024 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:19:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 03:10:30 PM
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology • GlobeNewswire Inc. • 02/21/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 01:06:03 PM
Vaccinex, Inc. Announces Reverse Stock Split • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:34 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:15:59 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:22:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:34:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:32:53 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/09/2024 09:08:11 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/08/2024 01:20:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 08:43:55 PM
Vaccinex Announces Pricing of $3.7 Million PIPE Financing • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/22/2024 05:15:30 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 09:40:09 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/10/2024 10:16:22 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/08/2024 09:16:04 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:31:17 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/28/2023 09:15:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 09:31:18 PM
Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule • GlobeNewswire Inc. • 12/04/2023 01:00:00 PM
Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM

More VCNX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover